Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis

Matthew Verdone; Jonathan Bauman; Esben Iversen; Rifka Schulman-Rosenbaum; Anthony Antonacci; Sabatino Leffe; Joseph Simpson; Yael Tobi Harris; Joseph Marino

doi:10.2337/ds23-0040

Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis

Diabetes Spectr. 2024 Spring;37(2):165-169. doi: 10.2337/ds23-0040. Epub 2024 Mar 15.

Authors

Matthew Verdone^{1

2}, Jonathan Bauman^{1

3}, Esben Iversen^{1

4}, Rifka Schulman-Rosenbaum^{1

5

6}, Anthony Antonacci^{1

7}, Sabatino Leffe^{1

6

8}, Joseph Simpson¹, Yael Tobi Harris^{1

5

6}, Joseph Marino^{1

3

6}

Affiliations

¹ Northwell, New Hyde Park, NY.
² Endoscopic and Advanced Endoscopic Anesthesia Services, Long Island Center for Digestive Health, Northwell Health, Uniondale, NY.
³ Department of Anesthesiology, Northwell Health, New Hyde Park, NY.
⁴ Department of Clinical Research, Copenhagen University Hospital Amager & Hvidovre, Hvidovre, Denmark.
⁵ Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Northwell Health, New Hyde Park, NY.
⁶ Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY.
⁷ Lenox Hill Hospital, Northwell Health, New York, NY.
⁸ South Shore University Hospital, Northwell Health, Bay Shore, NY.

PMID: 38756433
PMCID: PMC11093762 (available on 2025-03-01)
DOI: 10.2337/ds23-0040

No abstract available

Associated data

figshare/10.2337/figshare.25345750